LY-2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC₅₀ of 2 nM and 10 nM, respectively. LY-2835219 inhibits the p roliferation of Rb-positive tumor cells and demonstrates dose-dependent growth inhibition in ER+ breast cancer models

Numéro d'article : BIOVB1039-50
Unité de mesure : 50 MG
https://grogg-prod.braintec.cloud/web/image/product.template/929544/image_1920?unique=2d69762

625.00 CHF 625.0 CHF 625.00 CHF

625.00 CHF

Not Available For Sale

    Cette combinaison n'existe pas.

    Délai de livraison actuel sur demande

    Fabricant : BIOVISION
    Numéro du fabricant : B1039-50
    Température de stockage : Freezer (-20)

    LY-2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC₅₀ of 2 nM and 10 nM, respectively. LY-2835219 inhibits the p roliferation of Rb-positive tumor cells and demonstrates dose-dependent growth inhibition in ER+ breast cancer models